Effects of argon laser photocoagulation on rubeosis iridis and angle neovascularization.
Of 93 eyes with proliferative diabetic retinopathy treated by argon laser panretinal photocoagulation, two (2.2%) developed rubeosis. The incidence of rubeosis in five xenon-treated eyes was one (1.9%) and in an untreated group of 52 eyes, two (3.8%) developed rubeosis. The incidence of rubeosis in central retinal vein occlusion demonstrating retinal ischemia on fluorescein angiography was 60%, while in patients with central retinal vein occlusion and good capillary perfusion, the incidence of rubeosis only 1%. Panretinal photocoagulation was more effective in controlling rubeosis in diabetics than in patients with central retinal vein occlusion.
D001128:Argon; D003930:Diabetic Retinopathy / Q000150:complications / Q000601:surgery*; D005451:Fluorescein Angiography; D006801:Humans; D007498:Iris; D007511:Ischemia / Q000150:complications; D053685:Laser Therapy; D008028:Light Coagulation; D009389:Neovascularization, Pathologic; D012169:Retinal Vein; D014603:Uveal Diseases / Q000209:etiology; D014978:Xenon
D014978:Xenon; D001128:Argon